Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    51,074.77
    -572.41 (-1.11%)
     
  • CMC Crypto 200

    1,327.28
    -69.26 (-4.96%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Stryker planning takeover offer for Smith & Nephew - Bloomberg

(Adds share price movement)

Dec (Shanghai: 600875.SS - news) 23 (Reuters) - U.S. surgical implant maker Stryker Corp is planning a takeover offer for British medical device maker Smith & Nephew (LSE: SN.L - news) that may come within weeks, Bloomberg reported, citing people familiar with the matter.

According to the report, Stryker plans to offer a significant premium to Smith & Nephew's current share price, with one of the people saying it could be about 30 percent.

Smith & Nephew's London-listed shares rose 7.5 percent in early trading on Wednesday, to give it a market value of 10.6 billion pounds ($16.5 billion). Stryker shares closed up 1.7 percent at $96.61.

ADVERTISEMENT

Neither company could be reached for comment.

Analysts and bankers have speculated for years that the British company could be an attractive target for a company such as Stryker. The U.S. firm said in May that it was not working on a takeover offer, following similar media reports, which meant that under British takeover rules it could not make a bid for another six months.

According to Bloomberg, the bid is still being finalized and the timing could change. There's also a possibility that Stryker could decide against an offer, it quoted one of the people as saying.

Michigan-based Stryker is not considering a so-called "tax inversion" because of limited tax benefits and political risk, one of the people said, according to Bloomberg. ($1 = 0.6435 pounds) (Reporting by Rosmi Shaji in Bengaluru, additional reporting by Kate Holton; Editing by Kirti Pandey and Louise Heavens)